Sroll To Bottom
Latest news
03
Nov

2025

AAVantgarde Closes $141 Million Series B for Stargardt Disease and Usher 1B Syndrome clinical development
31
Oct

2025

Rafiq Hasan discusses Complement Tx’s FDA IND clearance to advance CTx001 into Opti-GAIN Phase I/II Trial in GA secondary to AMD on BiotechTV
30
Oct

2025

Anti-CEA affibody for improved cancer detection and imaging

Our services are thoughtfully crafted and constantly evolving to help achieve your goals

See us at...
We will be attending
17
Nov
Investival Showcase Europe 2025
17 November 2025
03
Dec
Genesis Conference 2025
3 December 2025
Testimonials